Older people with type 1 diabetes Insulin regimens in older adults should be individualised and patient safety is a key priority
That's potentially due to improved body composition quality, so more lean muscle mass preservation, less visceral fat, and better metabolic flexibility
Information presented here is based on published clinical trial data and may change as additional research becomes available.
Quick Meds will regularly review new evidence as it emerges and update prescribing policies accordingly, once Retatrutide becomes available
We are available Monday through Friday from 9 AM to 4:30 PM
The STEP 1 trial (Wilding et al., 2021), one of the largest studies on semaglutide, found that 39% of the weight lost over 68 weeks was lean mass